Format

Send to

Choose Destination
Antimicrob Agents Chemother. 2013 Nov;57(11):5710-3. doi: 10.1128/AAC.00726-13. Epub 2013 Aug 19.

The mevalonate auxotrophic mutant of Staphylococcus aureus can adapt to mevalonate depletion.

Author information

1
Microbial Genetics, Interfaculty Institute for Microbiology and Infection Medicine Tübingen (IMIT), University of Tübingen, Tübingen, Germany.

Abstract

In this study, we attempted to adopt the auxotrophic mevalonate synthase mutant (ΔmvaS mutant) of Staphylococcus aureus to study whether a nongrowing but viable cell population is tolerant to bactericidal antibiotics. The mevalonate-depleted nongrowing ΔmvaS mutant was found tolerant to antibiotics. Surprisingly, after prolonged cultivation, we obtained stable ΔmvaS variants that were able to grow without mevalonate, which suggested unknown mechanisms for compensating undecaprenyl pyrophosphate production without mevalonate in S. aureus.

PMID:
23959312
PMCID:
PMC3811321
DOI:
10.1128/AAC.00726-13
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center